Identifying metabolites of new psychoactive substances using in silico prediction tools
Archives of Toxicology · 2025
DOI: 10.1007/s00204-025-04049-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Romain Pelletier und 6 weiteren Autor:innen. Beteiligte Einrichtung: NuMeCan Institute (Nutrition, Metabolisms and Cancer), CHU Rennes, Univ Rennes, INSERM, INRAE, UMR_A 1341, UMR_S 1317, 35000, Rennes, France. romain.…. Hauptthemen laut MEDLINE: Computer Simulation, Psychotropic Drugs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre Hospitalier Universitaire de Rennes.
Abstract (Originalsprache)
New psychoactive substances (NPS) pose an increasing challenge for clinical and forensic toxicology due to the initial lack of analytical and metabolic data. This study evaluates the performance of four in silico prediction tools (GLORYx, BioTransformer 3.0, SyGMa, and MetaTrans) in predicting the metabolism of seven NPS from five major chemical families (cathinones, synthetic cannabinoids, synthetic opioids, designer benzodiazepines, and dissociative anesthetics). The predicted metabolites were compared to those reported in the literature. The results revealed that SyGMa was the most exhaustive tool, predicting 437 metabolites, whereas MetaTrans predicted the fewest (61). GLORYx uniquely identified glutathione conjugation, while BioTransformer was particularly effective in predicting phase I reactions. However, no single tool provided complete predictions. Combining the four tools enabled the identification of several key biomarkers consistent with experimental data, such as m/z 238.1443 for eutylone and m/z 381.1926 for etonitazepipne. These findings highlight the need for integrated approaches to optimize metabolite prediction. Future advancements in artificial intelligence-based models could reduce false positives and enhance the accuracy of predictions, thus reinforcing the role of in silico tools in toxicological investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NuMeCan Institute (Nutrition, Metabolisms and Cancer), CHU Rennes, Univ Rennes, INSERM, INRAE, UMR_A 1341, UMR_S 1317, 35000, Rennes, France. romain.pelletier@chu-rennes.fr.
- Clinical and Forensic Toxicology Laboratory, Rennes University Hospital, 35033, Rennes, France. romain.pelletier@chu-rennes.fr.
- NuMeCan Institute (Nutrition, Metabolisms and Cancer), CHU Rennes, Univ Rennes, INSERM, INRAE, UMR_A 1341, UMR_S 1317, 35000, Rennes, France.
- Clinical and Forensic Toxicology Laboratory, Rennes University Hospital, 35033, Rennes, France.
- Pharmacy Department, Rennes University Hospital, 35033, Rennes, France.
ORCID-Profile: Romain Pelletier
Förderung
- Centre Hospitalier Universitaire de Rennes
Zitieren
APA
Pelletier, R., Nahle, D., Sarr, M., Bourdais, A., Morel, I., Le Daré, B., & Gicquel, T. (2025). Identifying metabolites of new psychoactive substances using in silico prediction tools. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04049-5
Vancouver
Pelletier R, Nahle D, Sarr M, Bourdais A, Morel I, Le Daré B, et al. Identifying metabolites of new psychoactive substances using in silico prediction tools. Archives of Toxicology. 2025. doi:10.1007/s00204-025-04049-5
BibTeX
@article{Pelletier2025,
author = {Pelletier, Romain and Nahle, Dina and Sarr, Mareme and Bourdais, Alexis and Morel, Isabelle and Le Daré, Brendan and Gicquel, Thomas},
title = {Identifying metabolites of new psychoactive substances using in silico prediction tools},
journal = {Archives of Toxicology},
year = {2025},
doi = {10.1007/s00204-025-04049-5}
}
EUVIMED